Potential of Intranasal Delivery of Human Mesenchymal Stem Cells and Extracellular Vesicles for Stroke Therapy
{{output}}
Cerebral ischemic stroke, caused by interrupted cerebral blood flow, remains a leading cause of mortality and long-term disability worldwide. Current FDA-approved therapies-intravenous tissue-type plasminogen activator (tPA) and mechanical thrombectomy-are con... ...
